D.T. PACE Versus High Dose Melphalan and Autologous Transplant in Patients With Previously Treated Multiple Myeloma

NCT00083876 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Thalidomide

Sponsor

University of Arkansas

Collaborators

[object Object]